Get the Stockscreener App
1.44
5.26%
-0.08
Cabaletta Bio Inc stock is traded at $1.44, with a volume of 935.42K.
It is down -5.26% in the last 24 hours and down -7.69% over the past month.
Cabaletta Bio Inc is a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies and exploring their potential to provide a deep and durable, perhaps curative, treatment for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes Chimeric AutoAntibody Receptor, or CAART cells, that are designed to selectively bind and eliminate only specific B cells that produce disease-causing autoantibodies, or pathogenic B cells, while sparing normal B cells. Its CABA platform encompasses two strategies: CARTA (chimeric antigen receptor T cells for autoimmunity) and CAART (chimeric autoantibody T cells) that have the potential to be applied across a broad range of autoimmune diseases.
See More
Previous Close:
$1.52
Open:
$1.52
24h Volume:
935.42K
Relative Volume:
0.47
Market Cap:
$73.07M
Revenue:
-
Net Income/Loss:
$-67.68M
P/E Ratio:
-0.8675
EPS:
-1.66
Net Cash Flow:
$-54.24M
1W Performance:
-13.25%
1M Performance:
-7.69%
6M Performance:
-39.75%
1Y Performance:
-79.07%
1-Day Range:
$1.43
$1.55
1-Week Range:
$1.43
$1.7394
52-Week Range:
$0.9857
$6.74
Cabaletta Bio Inc Stock (CABA) Company Profile
Name
Cabaletta Bio Inc
Sector
Industry
Phone
(267) 759-3100
Address
2929 ARCH STREET, PHILADELPHIA, PA
Compare CABA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CABA
Cabaletta Bio Inc
|
1.44 | 136.71M | 0 | -67.68M | -54.24M | -1.66 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
Cabaletta Bio Inc Stock (CABA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-20-24 | Downgrade | Evercore ISI | Outperform → In-line |
| Dec-19-24 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Oct-10-24 | Initiated | UBS | Buy |
| Feb-05-24 | Initiated | Jefferies | Buy |
| Nov-29-23 | Initiated | William Blair | Outperform |
| Oct-24-23 | Initiated | Cantor Fitzgerald | Overweight |
| Oct-19-23 | Initiated | Stifel | Buy |
| Sep-05-23 | Initiated | Citigroup | Buy |
| Jul-18-23 | Initiated | Guggenheim | Buy |
| Jan-27-23 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Aug-30-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Dec-08-21 | Initiated | Wells Fargo | Overweight |
| Oct-19-21 | Resumed | Morgan Stanley | Overweight |
| Jun-30-21 | Initiated | Mizuho | Buy |
| Jan-08-21 | Initiated | Chardan Capital Markets | Buy |
| Oct-13-20 | Initiated | H.C. Wainwright | Buy |
| Nov-19-19 | Initiated | Cowen | Outperform |
| Nov-19-19 | Initiated | Evercore ISI | Outperform |
| Nov-19-19 | Initiated | Morgan Stanley | Overweight |
View All
Cabaletta Bio Inc Stock (CABA) Latest News
What are Cabaletta Bio Inc. company’s key revenue driversAdvanced Screener Report With Low Risk - jammulinksnews.com
What is the risk reward ratio of investing in Cabaletta Bio Inc. stockStock Strategy Trend Scanner For Every Investor - jammulinksnews.com
What’s the recovery path for long term holders of Cabaletta Bio Inc.Multi-Bagger Potential Stock Forecast Tools Released - metal.it
Is it the right time to buy Cabaletta Bio Inc. stockStock Strategy Tracker For Every Investor - jammulinksnews.com
Cabaletta Bio Inc. Company’s Quarterly Earnings Growth: What the Numbers SayDaily Chart Pattern Stock Forecast Shows Bullish Setup - metal.it
Why Cabaletta Bio Inc. stock attracts strong analyst attentionExit Ready Momentum Stock Watchlist Expanded - metal.it
Is Cabaletta Bio Inc. a growth stock or a value stockRetirement Planning Watchlist For Fast Growth - jammulinksnews.com
What catalysts could drive Cabaletta Bio Inc. stock higher in 2025Breakout Stocks Opportunities That Work - jammulinksnews.com
How volatile is Cabaletta Bio Inc. stock compared to the marketChart Pattern Updates With High Returns - jammulinksnews.com
What makes Cabaletta Bio Inc. stock price move sharplyMarket-beating performance - jammulinksnews.com
Applying big data sentiment scoring on Cabaletta Bio Inc.High Return Strategy with Low Risk - Newser
Key resistance and support levels for Cabaletta Bio Inc.Market Correction Proof Stock Screening Analysis - Newser
How to track smart money flows in Cabaletta Bio Inc. Profit Target Planning with Exit Confidence - Newser
How strong is Cabaletta Bio Inc. company’s balance sheetMaximize your portfolio’s earning power - jammulinksnews.com
Should I hold or sell Cabaletta Bio Inc. stock in 2025Build a winning investment strategy - jammulinksnews.com
When is Cabaletta Bio Inc. stock expected to show significant growthInvest in stocks with strong fundamentals - jammulinksnews.com
How does Cabaletta Bio Inc. generate profit in a changing economyOutperformance with explosive growth - jammulinksnews.com
Cabaletta Bio Inc. Company Revenue and Profit Trends: A Deep Dive200 Percent Watchlist - metal.it
What is Cabaletta Bio Inc. company’s growth strategyAchieve unparalleled market performance - jammulinksnews.com
Will Cabaletta Bio Inc. Stock Benefit from AI and Green Energy TrendsIntraday Trade Ideas - metal.it
Is Cabaletta Bio Inc. Stock Overbought or Oversold RSI Indicator Analysis - Newser
How Resilient Is Occidental Petroleum Corporation Stock During Economic Downturns3x Return Stock Radar - Newser
What drives Cabaletta Bio Inc. stock priceRapid market gains - PrintWeekIndia
Why Cabaletta Bio Inc. stock is on top investor watchlistsSkyrocketing returns - jammulinksnews.com
What analysts say about Cabaletta Bio Inc. stockHigh-yield capital appreciation - Autocar Professional
Cabaletta Bio Inc. Stock Analysis and ForecastFree Stock Chart Pattern Guide - jammulinksnews.com
Is Cabaletta Bio Inc. a good long term investmentUnprecedented profits - jammulinksnews.com
Will Cabaletta Bio Inc. stock benefit from interest rate changesPredictable High Return Trades - Newser
Cabaletta Bio’s RESET-SLE Study: A Promising Step in Lupus Treatment - TipRanks
Cabaletta Bio Inc Stock (CABA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):